Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisa S Grassi

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Neoplasia (New York, N.Y.)|November 3, 2020
Niche-derived soluble DLK1 promotes glioma growthElisa S Grassi, Pauline Jeannot, Vasiliki Pantazopoulou, et al.
Plos One|June 23, 2011
8-Chloro-cyclic AMP and protein kinase A I-selective cyclic AMP analogs inhibit cancer cell growth through different mechanismsSimona Lucchi, Davide Calebiro, Tiziana de Filippis, et al.
Minerva Endocrinologica|February 2, 2017
Tumor and normal thyroid spheroids: from tissues to zebrafishValentina Cirello, Germano Gaudenzi, Elisa S Grassi, et al.
Cell Reports|August 17, 2017
CD44 Interacts with HIF-2α to Modulate the Hypoxic Phenotype of Perinecrotic and Perivascular Glioma CellsElinn Johansson, Elisa S Grassi, Vasiliki Pantazopoulou, et al.
Molecular Oncology|April 29, 2017
Synergistic activity of everolimus and 5-aza-2'-deoxycytidine in medullary thyroid carcinoma cell linesGiovanni Vitale, Alessandra Dicitore, Daniele Pepe, et al.
The Journal of Clinical Investigation|August 9, 2016
Recurrent EZH1 mutations are a second hit in autonomous thyroid adenomasDavide Calebiro, Elisa S Grassi, Markus Eszlinger, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Neoplasia (New York, N.Y.)|November 3, 2020
Niche-derived soluble DLK1 promotes glioma growthElisa S Grassi, Pauline Jeannot, Vasiliki Pantazopoulou, et al.
Plos One|June 23, 2011
8-Chloro-cyclic AMP and protein kinase A I-selective cyclic AMP analogs inhibit cancer cell growth through different mechanismsSimona Lucchi, Davide Calebiro, Tiziana de Filippis, et al.
Minerva Endocrinologica|February 2, 2017
Tumor and normal thyroid spheroids: from tissues to zebrafishValentina Cirello, Germano Gaudenzi, Elisa S Grassi, et al.
Cell Reports|August 17, 2017
CD44 Interacts with HIF-2α to Modulate the Hypoxic Phenotype of Perinecrotic and Perivascular Glioma CellsElinn Johansson, Elisa S Grassi, Vasiliki Pantazopoulou, et al.
Molecular Oncology|April 29, 2017
Synergistic activity of everolimus and 5-aza-2'-deoxycytidine in medullary thyroid carcinoma cell linesGiovanni Vitale, Alessandra Dicitore, Daniele Pepe, et al.
The Journal of Clinical Investigation|August 9, 2016
Recurrent EZH1 mutations are a second hit in autonomous thyroid adenomasDavide Calebiro, Elisa S Grassi, Markus Eszlinger, et al.
Pageof 1